Affiliation: NV Organon
Country: The Netherlands
- Frontotemporal dementia--a brief reviewMagnus Sjogren
Department of Experimantal Geriatrics, Neurotec, Karolinska Institute, Huddinge, Sweden
Mech Ageing Dev 127:180-7. 2006..Since there is no curative, treatment of prevailing symptoms is the given alternative. Serotonergic acting drugs have been shown to alleviate behavioural symptoms...
- Cholesterol and Alzheimer's disease--is there a relation?Magnus Sjogren
Department of Experimental Geriatrics, Neurotec, Karolinska Institute, Huddinge, Sweden
Mech Ageing Dev 127:138-47. 2006..e., alpha-secretase and beta-secretase. This normalises the breakdown of APP thereby promoting the non-amyloidogenic pathway. In this review, investigations focusing on cholesterol and Alzheimer's disease are presented...
- The link between cholesterol and Alzheimer's diseaseMagnus Sjogren
Section of Experimental Geriatrics, Neurotec, Karolinska Institute KFC, Novum Plan 4, SE 14186 Huddinge, Sweden
World J Biol Psychiatry 6:85-97. 2005..e. beta-secretase. This normalises the breakdown of the precursor of Abeta, amyloid precursor protein, thereby promoting the nonamyloidogenic pathway. This review focusses on the link between cholesterol and Alzheimer's disease...
- CSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42Niels Andreasen
Karolinska Institute NEUROTEC, Neurotec, Huddinge University Hospital, Sweden
World J Biol Psychiatry 4:147-55. 2003..We stress that the CSF markers should be combined with the clinical information and brain-imaging techniques...